COMPOSITION OF MONOTERPENOIDS HAVING BACTERICIDAL PROPERTIES
申请人:Reynolds Max
公开号:US20140039045A1
公开(公告)日:2014-02-06
A composition having bactericidal properties comprising; (a) 30%-80% of at least one compound having the formula (I) and (b) 10% to 40% of at least one compound of formula (II)
US9023888B2
申请人:——
公开号:US9023888B2
公开(公告)日:2015-05-05
[EN] COMPOSITIONS OF MONOTERPENOIDS FOR THE TREATMENT OF AN HIV INFECTION<br/>[FR] MÉTHODE POUR LE TRAITEMENT D'UNE INFECTION À VIH
申请人:REYNOLDS MAX
公开号:WO2012104567A1
公开(公告)日:2012-08-09
The invention concerns use of a composition for the treatment and prophylaxis of an HIV infection in a patient. The composition comprises a mixture of 30% - 80% of at least one compound having the formula (I) and 10% to 40% of at least one compound of the formula (II) wherein the substituents are as defined in the description. The invention also relates to methods for the treatment and prophylaxis of an HIV infection and also use of the composition in the preparation of a medicament for treatment of an HIV infection.
[EN] COMPOSITIONS OF MONOTERPENOIDS FOR STIMULATING THE IMMUNE SYSTEM<br/>[FR] COMPOSITION DE MONOTERPÉNOÏDES POUR STIMULER LE SYSTÈME IMMUNITAIRE
申请人:REYNOLDS MAX
公开号:WO2012104568A1
公开(公告)日:2012-08-09
The invention concerns use of a composition for stimulating the immune system in a mammal. The composition comprises a mixture of 30% - 80% of at least one compound having the formula (I) and 10% to 40% of at least one compound of the formula (II) wherein the substituents are as defined in the description. The invention also relates to use of the composition in the preparation of a medicament for stimulation of the immune system in a mammal.
[EN] COMPOSITION OF MONOTERPENOIDS FOR THE TREATMENT OF CANCER<br/>[FR] COMPOSITION DE MONOTERPENOÏDES POUR LE TRAITEMENT DE CANCER
申请人:REYNOLDS MAX
公开号:WO2012104569A1
公开(公告)日:2012-08-09
The invention concerns use of a composition for the treatment and prophylaxis of cancer in a mammal. The composition comprises a mixture of 30% - 80% of at least one compound having the formula (I) (Formula (I)) and 10% to 40% of at least one compound of the formula (II) (Formula (II)) wherein the substituents are as defined in the description. The invention also relates to methods for the treatment and prophylaxis of cancer and also use of the composition in the preparation of a medicament for treatment or prophylaxis of cancer.